Tag: Tavapadon

Parkinson's disease is the world's fastest-growing neurological disorder, with projections suggesting over 25 million people could be affected by 2050 [1.6.1, 1.6.3]. This escalating health challenge drives a pressing search for better treatments. So, what is the new pill for Parkinson's disease? Several promising options have recently emerged.

According to the Parkinson's Foundation, around one million people in the United States have Parkinson's disease. The newest FDA-approved drug for Parkinson's disease in 2025 is Onapgo (apomorphine hydrochloride), a continuous infusion therapy for managing motor fluctuations in advanced patients.